Fundamental Analysis of Abcellera Biologics Inc - Growth / Value Index


ABCL - Valuation Highlights

Valuation Analysis

   Book Value in last 3 years is trending up
   Tsr Value Index - Very Poor Score of 9.38
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -5.52 -6.28 -213.39 %
Price to Book 0.982 0.704 -1.13 % 0.658
Price to Sales 22.65 16.10 789.87 %
Enterprise Value to EBITDA Multiple -4.56 -7.44 -513.06 %


ABCL - Profitability Highlights

Profitability Analysis

   Piotroski F Score - Stable Value of 4.0
   Tsr Profitability Index - Very Poor Score of 5.00
   Very Low Dividend Yield of 0 %
   Company Net profit is Negative for last 5 Quarters
   Negative Net Margin MRQ
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity -12.52 -11.21 -187.19 % -3.59
Return On Asset -13.00 -8.68 -184.36 % -2.78
Net Profit Margin -410.47 -256.28 -884.79 % -407.98
Operating Profit Margin -625.49 -389.91 -933.55 % -551.48
EBITDA Margin -425.01 -182.56 -420.81 % -483.50


Highlights
Market Cap820410 K
Enterprise Value693248 K
Price/Book TTM0.982
Outstanding Share294054 K
Float/ Outstanding Share67.52%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score4.00
Altman Z Score2.10
Sloan Ratio-0.091
Peter Lynch Fair Value0


ABCL - Growth Highlights

Growth Analysis

   Tsr Growth Index - Poor Score of 28.05
   Companies' sales dropped by 89.62 % from last year
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 35788.00 K 89.62 % 8.44 %
Gross Profit 29022.00 K 88.34 % 65.27 %
EBITDA -152104.00 K 133.30 % 26.52 %
Net Profit -146898.00 K 181.47 % 13.87 %
EPS -0.506 188.19 % NA


ABCL - Stability Highlights

Stability Analysis

   Cash ratio of 6.39
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of 0
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 0.0053 18.05 % 0.0049
Cash Ratio 6.39 -14.70 %
Quick Ratio 7.32 -15.45 % 7.75
Shareholders Equity 77.44 -3.25 %
Debt to EBITDA -0.067 -431.21 %


Historical Valuation Ratios of Abcellera Biologics Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Abcellera Biologics Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Abcellera Biologics Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Abcellera Biologics Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)